4
Changes in Ownership
ARS Pharmaceuticals, Inc. Filed Acc 0001415889-24-029851
PRESIDENT AND CEO sold 100,000 shares at an average $11.67 ($1,167,100)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lowenthal Richard E PRESIDENT AND CEO | 2024-12-17 | Sale 10b5-1 | −50,000 | $11.67 | $583,575 | 1,297,447 | I |
| Lowenthal Richard E PRESIDENT AND CEO | 2024-12-17 | Sale 10b5-1 | −50,000 | $11.67 | $583,525 | 1,098,499 | I |
| Open-market sales · 100,000 sh · avg $11.67 · $1,167,100 | |||||||
Loading xslF345X05/form4-12192024_041201.xml…